FINWIRES · TerminalLIVE
FINWIRES

$UNH

52 stories mentioning UNH

Every FINWIRES story that references UNH, newest first.

Dow Logs New High Even as Tech Underperforms
US Markets

Dow Logs New High Even as Tech Underperforms

The Dow Jones Industrial Average resumed its record-setting advance on Thursday, even as the technology sector underperformed amid a sell-off in Broadcom (AVGO) and CrowdStrike (CRWD) shares.The Dow rose 1.7% to 51,561.9, notching a fresh closing high after falling on Wednesday for the first time in six sessions. The S&P 500 gained 0.4% to 7,584.3, while the Nasdaq Composite fell 0.1% to 26,831.Barring tech and consumer staples, all sectors ended in the green, led by healthcare.In company news, Broadcom shares tumbled nearly 13%, the second-worst performer on the S&P 500 as the company's artificial intelligence revenue outlook fell short of the market's bullish expectations.The company's decision not to upgrade its 2027 guidance for AI sales apparently disappointed investors, especially as the chip designer reported strong semiconductor demand for its fiscal second quarter, UBS Securities analysts said.CrowdStrike reported strong fiscal first-quarter results amid accelerating demand for AI, but questions around performance sustainability remain, BofA Securities said. The stock fell 3.8%.Ciena (CIEN) plunged nearly 14%, the steepest decline on the S&P 500, despite providing an upbeat fiscal third-quarter revenue outlook. The networking systems and software company's results topped market estimates in the prior three-month period."AI and cybersecurity remain important long-term themes, but popular themes can carry heavy expectations," Ruben Dalfovo, investment strategist at Saxo Bank, said in a report. "In a hot market, even excellent earnings may need to bring their own fire extinguisher."UnitedHealth (UNH) climbed 5.2%, the top gainer on the Dow, after BofA Securities upgraded its rating on the stock to buy from neutral.West Texas Intermediate crude oil was down 3% at $93.19 a barrel in Thursday late-afternoon trade, while Brent fell 2.6% to $95.30.Israel and Lebanon agreed to implement a ceasefire, subject to Iran-backed Hezbollah ending all fire and evacuating its operatives from the South Litani Sector, according to a joint statement from the US, Israel and Lebanon released Wednesday.But just hours after the deal, Israeli forces and Hezbollah fighters launched strikes, CNN reported."News that Israel and Lebanon agreed on a ceasefire could potentially open the door for talks to advance," ING Bank said in a report on Thursday. "Every day that passes without a resumption of oil flows (through the Strait of Hormuz) leaves the market increasingly vulnerable. This increases the pressure to strike a deal."In economic news, job cut announcements in May hit the highest for the month since 2020, Challenger, Gray & Christmas said Thursday, while US weekly applications for unemployment insurance rose unexpectedly."On top of the headline AI story, we're seeing a sharp rise in cuts tied to acquisitions and mergers and a jump in bankruptcy-related losses, which tells me companies are restructuring aggressively as they reposition for an AI-driven economy," Andy Challenger, the firm's chief revenue officer, said in a statement. "The labor market is being reshaped by technology in real time."The Challenger report arrives a day before the May nonfarm payrolls release. Economists surveyed by Bloomberg expect 85,000 new jobs, down from 115,000 in April, with the unemployment rate seen holding at 4.3%.US Treasury yields were lower, with the 10-year rate down 2.4 basis points at 4.48%, and the two-year rate falling three basis points to 4.06%.Gold was last up 0.9% at $4,507 per troy ounce, while silver rose 0.8% to $74.31 per ounce.

Dow JonesNasdaq CompositeS&P 500$AVGO$CIEN$CRWD$UNH
Sectors

Sector Update: Healthcare Stocks Climb Late Afternoon

Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index climbing 3.2% and the State Street Health Care Select Sector SPDR ETF (XLV) rising 3%.The iShares Biotechnology ETF (IBB) added 2.6%.In corporate news, Eli Lilly (LLY) shares gained 4.3% after Ascidian Therapeutics said Lilly will receive exclusive, target-specific rights to Ascidian's RNA exon editing technology for undisclosed kidney disease targets in exchange for up to $1.9 billion under a research partnership and licensing deal.Merck (MRK) shares climbed 5% after it said Thursday it will pay over $50 million to settle more than 200 lawsuits that blame the drugmaker's Gardasil cancer vaccine for causing autoimmune ailments in young women, Bloomberg reported.The US Supreme Court on Thursday ruled that Amarin (AMRN) failed to prove that a generic-drug manufacturer actively induced other companies to infringe upon two of its Vascepa patents after the generic maker received approval for a so-called "skinny-label" version of the drug. Amarin shares fell 4.4%.BofA Securities upgraded UnitedHealth (UNH) to buy from neutral as medical cost trends improve and "supportive" near-term data points form a favorable Q2. UnitedHealth shares rose 5.4%.

$AMRN$LLY$MRK$UNH
Equities Higher Intraday as Broadcom Sell-Off Weighs on Tech Sector
US Markets

Equities Higher Intraday as Broadcom Sell-Off Weighs on Tech Sector

US benchmark equity indexes were higher intraday, even as a sell-off in Broadcom (AVGO) shares weighed on the technology sector.The Dow Jones Industrial Average was up 1.6% at 51,517.2 after midday Thursday, while the S&P 500 rose 0.4% to 7,586.8. The Nasdaq Composite edged up 0.1% to 26,872. Barring technology and materials, all sectors were in the green, led by healthcare.In company news, Broadcom shares were down nearly 12% intraday, the second-worst performer on the S&P 500 as the company's artificial intelligence revenue outlook fell short of the market's bullish expectations.The company's decision not to upgrade its 2027 guidance for AI sales apparently disappointed investors, especially as the chip designer reported strong semiconductor demand for its fiscal second quarter, UBS Securities analysts said.CrowdStrike (CRWD) reported strong fiscal first-quarter results amid accelerating demand for artificial intelligence, but questions around the company's performance sustainability remain, BofA Securities said. The stock was down 4.6%.Ciena (CIEN) plunged 15% despite providing an upbeat fiscal third-quarter revenue outlook on Thursday. The networking systems and software company's results topped market estimates in the prior three-month period.UnitedHealth (UNH) was up 5% intraday, the top gainer on the Dow, after BofA Securities upgraded its rating on the stock to buy from neutral.West Texas Intermediate crude oil was down 3.9% at $92.27 a barrel intraday Thursday, while Brent fell 3.2% to $94.67.Israel and Lebanon agreed to implement a ceasefire, subject to Iran-backed Hezbollah ending all fire and evacuating its operatives from the South Litani Sector, according to a joint statement from the US, Israel and Lebanon released Wednesday.But just hours after the deal, Israeli forces and Hezbollah fighters launched strikes, CNN reported."News that Israel and Lebanon agreed on a ceasefire could potentially open the door for talks to advance," ING Bank said in a report on Thursday. "Every day that passes without a resumption of oil flows (through the Strait of Hormuz) leaves the market increasingly vulnerable. This increases the pressure to strike a deal."In economic news, job cut announcements in May hit the highest for the month since 2020, Challenger, Gray & Christmas said Thursday, while US weekly applications for unemployment insurance rose unexpectedly."On top of the headline AI story, we're seeing a sharp rise in cuts tied to acquisitions and mergers and a jump in bankruptcy-related losses, which tells me companies are restructuring aggressively as they reposition for an AI-driven economy," Andy Challenger, the firm's chief revenue officer, said in a statement. "The labor market is being reshaped by technology in real time."The Challenger report arrives a day before the May nonfarm payrolls release. Economists surveyed by Bloomberg expect 85,000 new jobs, down from 115,000 in April, with the unemployment rate seen holding at 4.3%.US Treasury yields were lower intraday, with the 10-year rate down 2.8 basis points at 4.47%, and the two-year rate falling 3.3 basis points to 4.05%.Gold was up 0.9% at $4,508.50 per troy ounce, while silver rose 0.8% to $74.28 per ounce.

Dow JonesNasdaq CompositeS&P 500$AVGO$CIEN$CRWD$UNH
Sectors

Sector Update: Healthcare Stocks Gain Thursday Afternoon

Healthcare stocks were higher Thursday afternoon, with the NYSE Healthcare Index climbing 3.2% and the State Street Health Care Select Sector SPDR ETF (XLV) rising 2.8%.The iShares Biotechnology ETF (IBB) added 2.2%.In corporate news, Eli Lilly (LLY) shares climbed 5% after Ascidian Therapeutics said Lilly will receive exclusive, target-specific rights to Ascidian's RNA exon editing technology for undisclosed kidney disease targets in exchange for up to $1.9 billion under a research partnership and licensing deal.Merck (MRK) shares rose 3.9% after it said Thursday it will pay over $50 million to settle more than 200 lawsuits that blame the drugmaker's Gardasil cancer vaccine for causing autoimmune ailments in young women, Bloomberg reported.BofA Securities upgraded UnitedHealth (UNH) to buy from neutral as medical cost trends improvement and "supportive" near-term data points form a favorable Q2. UnitedHealth shares gained 5.2%.

$LLY$MRK$UNH
Wire

UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says

UnitedHealth (UNH), CVS Health (CVS) and Cigna (CI) are among the managed-care companies that could benefit from improving utilization trends and potential artificial intelligence-driven efficiency gains across the healthcare system, Morgan Stanley said in a note Thursday.The firm said early signs of softer utilization have supported recent gains in managed-care stocks. The group has delivered a series of medical-loss-ratio beats in Q1 and some companies raising guidance. However, it noted that investors are still awaiting clearer confirmation of underlying trends and utilization signals remaining mixed ahead of Q2 results.AI adoption is increasingly embedded across managed-care operations, including prior authorization, call centers, provider portals, care management, pharmacy utilization and payment integrity.Morgan Stanley said UnitedHealth stands out as a leading "AI enabler," particularly through Optum Insight initiatives, which support both efficiency gains and potential revenue upside.The firm's scenario analysis assumes 0.5% to 2.0% AI-driven insurance margin expansion, which could translate into an illustrative 18% to 71% EPS upside across managed-care companies. It added that administrative workflows, particularly prior authorization, remain key areas of automation potential.Morgan Stanley boosted its price targets on UnitedHealth, CVS Health, Elevance Health (ELV), Centene (CNC), Molina Healthcare (MOH), and Humana (HUM).Price: $399.90, Change: $+22.90, Percent Change: +6.07%

$CI$CNC$CVS$ELV$HUM$MOH$UNH
Research

Update: BofA Securities Upgrades UnitedHealth to Buy From Neutral, $450 Price Target

(Updated to include BofA's commentary)BofA Securities upgraded UnitedHealth (UNH) to buy from neutral as medical cost trends improvement and "supportive" near-term data points form a favorable Q2.If utilization trends continue to moderate, the brokerage believes the company-given its bellwether status-should lead a broader MCO rally, analysts led by Kevin Fischbeck wrote in a Thursday note.UnitedHealth has an average rating of overweight and mean price target of $404.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $399.70, Change: $+22.70, Percent Change: +6.02%

$UNH
Wire

UnitedHealth's 'Favorable' Q2 Setup Driven by Improving Medical Cost Trends, BofA Says

UnitedHealth's (UNH) "favorable" Q2 earnings setup and attractive risk/reward are driven by improving medical cost trends and supportive near-term data points, BofA Securities said in a Thursday research report.BofA said it now expects EPS for 2026, 2027, and 2028 of $18.70, $21, and $24, respectively, from $18.30, $20.17, and $22.34 earlier.The company is guiding to the low-end of target margins by 2028, but even then, it would be well-positioned to grow earnings by at least 13% to 16% in the coming years, given that Optum Health and Medicaid would have room to lift margins back to the midpoint of target, analysts wrote.While the company's benefit cuts this year make it difficult to perform well, its contracts remain relatively diversified, according to the note.The brokerage said it upgraded the stock to buy from neutral and boosted its price target to $450 from $420.Price: $399.43, Change: $+22.43, Percent Change: +5.95%

$UNH
Research

BofA Securities Upgrades UnitedHealth to Buy From Neutral, Price Target is $450

UnitedHealth (UNH) has an average rating of overweight and mean price target of $404.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$UNH
Sectors

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks rose late Monday afternoon, with the NYSE Healthcare Index and the State Street Healthcare Select Sector SPDR ETF (XLV) each adding 0.4%.The iShares Biotechnology ETF (IBB) was shedding 1.6%.In corporate news, Boston Scientific (BSX) shares jumped 6% after it said Monday that it invested $1.5 billion for an approximately 34% stake in privately held MiRus, gaining an exclusive option to acquire the company's TAVR business. Separately, Boston Scientific entered into a $2 billion accelerated share repurchase agreement with JPMorgan Chase (JPM) as part of its $5 billion share buyback authorization.Claritev (CTEV) shares jumped past 19% after the company issued a response to a Thursday media article stating that the Department of Justice has launched a criminal probe into Claritev. The company said Monday it has not been informed by the DOJ that it is the target of an investigation at no point in the subsequent two years after receiving a 2024 subpoena.Eli Lilly (LLY) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders. Lilly shares fell 1.7%.Berkshire Hathaway (BRK.A, BRK.B) said Friday in a regulatory filing that it sold all of its stake in UnitedHealth (UNH). UnitedHealth shares were down 0.8%.

$BSX$CTEV$LLY$UNH
Sectors

Sector Update: Healthcare Stocks Advance Monday Afternoon

Healthcare stocks rose Monday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Healthcare Select Sector SPDR ETF (XLV) up 0.3%.The iShares Biotechnology ETF (IBB) was shedding 1.5%.In corporate news, Claritev (CTEV) shares jumped 28% after the company issued a response to a Thursday media article stating that the Department of Justice has launched a criminal probe into Claritev. The company said Monday it has not been informed by the DOJ that it is the target of an investigation at no point in the subsequent two years after receiving a 2024 subpoena.Eli Lilly (LLY) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders. Lilly shares fell 1.4%.Berkshire Hathaway (BRK.A, BRK.B) said Friday in a regulatory filing that it sold all of its stake in UnitedHealth (UNH). UnitedHealth shares were down 1.4%.

$CTEV$LLY$UNH
Wire

Top Midday Stories: NextEra, Dominion to Combine in All-Stock Deal; Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

The Dow Jones Industrial Average, Nasdaq Composite and S&P 500 Index were down in late-morning trading Monday, as Wall Street monitored oil prices and US Treasury yields amid the ongoing conflict in the Middle East.In company news, NextEra Energy (NEE) and Dominion Energy (D) said Monday they have entered into a definitive agreement to combine in an all-stock deal. Under the terms of the transaction, Dominion shareholders will receive a fixed exchange ratio of 0.8138 shares of NextEra for each Dominion share they own at the close of the deal, which is expected in the next 12 to 18 months. NextEra shareholders will own about 74.5% of the combined company, while Dominion shareholders will own the remaining 25.5%. NextEra shares were down 5.5% around midday, while Dominion shares were up 9.6%.The US Supreme Court on Monday denied writ of certiorari petitions by six big pharmaceutical companies seeking to challenge the legality of the Medicare Drug Price Negotiation Program under the Inflation Reduction Act of 2022. AstraZeneca (AZN), Novartis (NVS), Novo Nordisk (NVO), Johnson & Johnson's (JNJ) Janssen Pharmaceuticals, Bristol-Myers Squibb (BMY) and Boehringer Ingelheim Pharmaceuticals all had their petitions denied by the Supreme Court. Shares of AstraZeneca, Novartis, Johnson & Johnson and Bristol-Myers were up 1.1%, 0.8%, 0.4% and 0.5%, respectively, while Novo Nordisk was down 1%.Berkshire Hathaway (BRK.A, BRK.B) disclosed Friday in a regulatory filing that it sold all of its stake in UnitedHealth Group (UNH). Separately, a New York state court judge on Monday prohibited prosecutors from using some evidence found in the backpack of Luigi Mangione, who is standing trial for the murder of UnitedHealth Group's UnitedHealthcare CEO Brian Thompson, CNBC reported. UnitedHealth shares were down 1.5%, while Berkshire's class A and class B shares were up 0.2% and 0.1%, respectively.Citigroup (C) and BlackRock's (BLK) HPS Investment Partners are launching a 15 billion euro ($17.48 billion) private capital program to expand access to private financing for corporate and sponsor-owned borrowers in the Europe, the Middle East and Africa region, the companies said Monday. Citigroup shares were down 0.2%, while BlackRock shares were up 0.5%.Price: $88.24, Change: $-5.13, Percent Change: -5.49%

$AZN$BLK$BMY$BRK.A$BRK.B$C$D$JNJ$NEE$NVO$NVS$UNH
Wire

Market Chatter: State Judge in UnitedHealthcare CEO Murder Case Blocks Mangione Backpack Evidence

A judge in New York state court on Monday prohibited prosecutors from using some evidence from the backpack of Luigi Mangione, who is standing trial for the murder of UnitedHealth Group's (UNH) UnitedHealthcare CEO Brian Thompson, CNBC reported.UnitedHealth didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $385.72, Change: $-8.13, Percent Change: -2.06%

$UNH
Wire

State Judge in UnitedHealthcare CEO Murder Case Blocks Mangione Backpack Evidence, CNBC Reports

State Judge in UnitedHealthcare CEO Murder Case Blocks Mangione Backpack Evidence, CNBC Reports

$UNH
Wire

UnitedHealth Group Shares Drop After Berkshire Sell Stake in Health Firm

UnitedHealth Group (UNH) shares fell 2.2% in early trading on Monday after Berkshire Hathaway (BRK.A, BRK.B) disclosed in a regulatory filing on Friday that it had sold all of its stake in the healthcare company.In August 2025, Berkshire had acquired about 5 million shares UnitedHealth.Trading volume stood at over 9.6 million against a daily average of around 8.5 million.Price: $386.30, Change: $-7.53, Percent Change: -1.91%

$BRK.A$BRK.B$UNH
Stocks Fall Pre-Bell as Traders Monitor US-Iran Tensions, Await Nvidia Earnings
US Markets

Stocks Fall Pre-Bell as Traders Monitor US-Iran Tensions, Await Nvidia Earnings

The benchmark US stock measures were tracking in the red before the opening bell Monday as investors monitor the ongoing US-Iran tensions and await the latest financial results of tech bellwether Nvidia (NVDA) later in the week.The S&P 500 declined 1.3%, the Dow Jones Industrial Average dropped 0.6% and the Nasdaq was off 0.1% in premarket activity. The indexes finished Friday trading lower.Tensions between the US and Iran remain in focus amid no apparent progress toward a peace deal between the two sides. President Donald Trump said in a social media post on Sunday that the "clock is ticking" for Iran to agree to a deal and that "they better get moving, fast, or there won't be anything left of them."Iran's semi-official Fars news agency said the US has set five main conditions for a peace deal, including transferring uranium tied to Tehran's nuclear program to Washington, Bloomberg News reported. Iran's Mehr news agency reportedly said the US has offered "no tangible concessions" to Tehran.A drone attack caused a fire at a nuclear power plant in the United Arab Emirates on Sunday, while Saudi Arabia said it intercepted three drones that entered from Iraqi airspace, according to CNBC.West Texas Intermediate crude oil rose 0.8% to $106.27 a barrel before the open, while Brent was up 0.7% to $110.08.Nvidia is scheduled to release its latest quarterly results after the markets close on Wednesday. "We fully expect the leading supplier of AI silicon will again exceed estimates and guide above Street given continued positive data points through (the calendar first quarter)," Wedbush Securities said in a Monday client note.Retail giants Walmart (WMT), Home Depot (HD), TJX (TJX), Lowe's (LOW) and Target (TGT) are also expected to announce their earnings this week.Treasury yields were trending higher in premarket action, with the two-year rate increasing 0.4 basis points to 4.09% and the 10-year rate adding 0.8 basis points to 4.6%.Monday's thin economic calendar has the housing market index for May at 10 am ET. Federal Reserve Bank of Atlanta interim President Cheryl Venable is slated to speak at 8:30 am.Shares of LiveRamp (RAMP) jumped 27% pre-bell after the data collaboration platform agreed to be acquired by French advertising and public relations firm Publicis Groupe in an all-cash deal with an enterprise value of about $2.17 billion. ServiceNow (NOW) was up nearly 3% while UnitedHealth (UNH) fell 4.9%.Gold slipped 0.4% to $4,544 per troy ounce, while bitcoin fell 2% to $76,723.

Dow JonesNasdaq CompositeS&P 500$HD$LOW$NOW$NVDA$RAMP$TGT$TJX$UNH$WMT
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Unitedhealth Group

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target to $440 from $385, 24x our 2026 EPS estimate (up $0.11 to $18.36; 2027 estimate up $0.64 to $20.76), a premium to UNH's 10-year historical forward average of 19.4x. Our target multiple is above most peers to reflect strong FCF generation, balance sheet strength, scale advantages, and a diversified business model across health insurance, pharmacy benefit management, health care technology and analytics, and outpatient facility networks. We are upgrading our 12-month fundamental outlook for the managed health care sub-industry to neutral from negative, with UNH and peers taking steps to improve profitability via increased medical premiums, strategic portfolio shifts/exits, and heightened focus on cost control within an elevated medical cost landscape. We anticipate that these actions may improve margins and profitability looking ahead to 2027-2028 and think valuations could gradually improve.

$UNH
Wire

UnitedHealthcare to Standardize Electronic Prior Authorization Requirements

UnitedHealth Group's (UNH) UnitedHealthcare said Friday that more than half of its prior authorization volume will be included in an industrywide effort to standardize submission requirements for electronic prior authorization.The company said it expects that proportion to rise to more than 70% by the end of 2026.The new standardized documentation process will apply across UnitedHealthcare's commercial, Medicare Advantage and Medicaid offerings, the company said.It added that it will be working aggressively to add more services and further reduce prior authorization requirements and volumes over the next several months.Price: $352.70, Change: $-1.81, Percent Change: -0.51%

$UNH
Wire

UnitedHealth Group Likely at Inflection Point After Strong Q1, Oppenheimer Says

UnitedHealth Group (UNH) could be at an inflection point as its operational initiatives gain traction and the rate/trend balance turn more favorable, Oppenheimer said in a note Tuesday.The company posted strong Q1 results, with adjusted earnings and revenue both higher year over year, and raised its adjusted EPS outlook to greater than $18.25 from its prior guidance of $17.75, the brokerage said.Early trends for UnitedHealth's segments exceeded expectations, Oppenheimer said, noting the OptumHealth division's outperformance. The Q1 results also absorbed higher operating costs with $900 million in incentive-comp and other investments, according to the note.The brokerage raised its 2026 EPS estimate for UnitedHealth to $18.27 from $17.77 previously.Oppenheimer increased its price target on UnitedHealth to $405 from $385, with an outperform rating.Price: $354.41, Change: $+8.40, Percent Change: +2.43%

$UNH
Wire

UnitedHealth Group's Turnaround Underway With Q1 Outperformance, Morgan Stanley Says

UnitedHealth Group's (UNH) better-than expected Q1 earnings and its surprise increase in 2026 EPS guidance are signs that the company's turnaround has started, and momentum is expected to continue with solid execution, Morgan Stanley said in a Wednesday note.The outperformance of Optum Health suggests that operational investments made in H2 of last year are beginning to pay off, along with improvements to contracts, Morgan Stanley analysts said.Artificial intelligence improvements, such as generative AI chatbot Avery and AI platform Optum Real, are reducing administrative burdens and improve clinical workflows, the analysts said. UnitedHealth is focused on the near-term impact of the AI tools, expecting the investments to provide a 2:1 financial return over the next few years, with many initiatives achieving payback within 12 to 18 months, the analysts noted.Morgan Stanley increased its projected 2026 EPS for UnitedHealth to $18.27 from $17.77 and 2027 EPS to $20.95 from $20.45.Morgan Stanley reiterated the company's stock as a "top pick" with rating of overweight and increased the price target to $395 from $375.Price: $357.73, Change: $+11.72, Percent Change: +3.39%

$UNH
Wire

Raymond James Adjusts Price Target on UnitedHealth Group to $370 From $330, Maintains Outperform Rating

UnitedHealth Group (UNH) has an average rating of overweight and mean price target of $378.54, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $356.14, Change: $+10.13, Percent Change: +2.93%

$UNH

Showing 1-20 of 52